Equity
€1.5m ▲ 2.7%
DR. KOEN SUY paid out €201,710 in dividends. That is 84% of the 2025 profit.
DR. KOEN SUY
Lifetime
19 annual accounts with figures on one time axis, 22 filings since 2003peak €454,505 (2024)
€432,542▼ 4.8%
lowest -€118,777 (2017)
€240,897▲ 27.6%
peak €1.5m (2025)
€1.5m▲ 2.7%
€875,851▲ 0.8%
Board1 name since 2009
1 directorSuy Koen
Documentsfilings and deeds
24-07-20267 days before the deadline
2025micro format
Result from €188,807 to €240,897Dividend €201,710
Key points
from the 2025 annual accountsResult
€240,897 ▲ 27.6%
The result rose in 2025 from €188,807 to €240,897.
Turnover
≈ €640,000 estimated
The micro format states no turnover.
Investments
€87,182 2.3 × depreciation
Green is investment, beige is depreciation. Land and buildings stand 83.4% higher than in 2024.
Filings
22 annual accounts since 2003
The last five annual accounts were filed 5 to 31 days before the end of the period.
Position in the sector
€1.5m
More equity than 95% of companies in human health. Sector median €124,628 · 20,776 companies.
Checked score
94
Excellent
Financially stronger than 49% of small companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 1,080 companies (NACE 86, small).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: < 0.1%
01-2025: < 0.1%● unchanged vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025highest value
08-2025: < 0.1%● unchanged vs 07-2025lowest value
09-2025: < 0.1%● unchanged vs 08-2025lowest value
10-2025: < 0.1%● unchanged vs 09-2025lowest value
11-2025: < 0.1%● unchanged vs 10-2025
12-2025: < 0.1%● unchanged vs 11-2025
01-2026: < 0.1%● unchanged vs 12-2025
02-2026: < 0.1%● unchanged vs 01-2026
03-2026: < 0.1%● unchanged vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthStrong
Score breakdown
lowers risk
Sector: Human health activities (NACE 86)
Size: total assets €2.3m
Liquidity: current ratio 2.53, cash €686,911
Figures for financial year 2025 (filed on 24-07-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small). It does better than 40% of them on solvency, 71% on liquidity, 52% on profitability and 32% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 20,137 companies had the same profile as DR. KOEN SUY has now. Each dot stands for 51 companies, two years later.
95.1%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
That fits the bankruptcy probability of DR. KOEN SUY itself: < 0.1% within 12 months.
Test of the method
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 20,137 companies, not a prediction for DR. KOEN SUY. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €130,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.53 (2.64 in 2024), above the usual 1.5. Short-term debt is 23.9% and cash 29.3% of total assets. 37.3% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
5 signals, none raises the risk
Five signals.
lowers riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
7 days early
2024
17 days early
2023
15 days early
2022
5 days early
2021
31 days early
2020
29 days early
2019
29 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 19 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 16 July (4 of the last 4 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0479097252
Amendment of the articles · Legal-form change · Resignations & appointments
General meeting of 04-04-2023 · Gazette deed
Boterlaarbaan 8 2970 'S Gravenwezel
General meeting of 30-12-2016 · Gazette deed
Incorporation
published on 30-12-2002 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DR. KOEN SUY Schilde | €2.3m | €432,542 | 62.7% | - |
| DR. DIRK VANHEMEL Olen | €2.2m | €533,701 | 70.6% | - |
| DR. PETER GEELEN Aalst | €1.7m | €375,500 | 97.4% | - |
| DE ROECK FILIP MEDISCHE BEELDVORMING Brasschaat | €1.8m | €590,628 | 85.9% | - |
| NOYA Uccle | €2.0m | €372,806 | 93.9% | - |
| M.O.N.D.E. Mouscron | €1.7m | €342,960 | 52.9% | - |
| Dr. P. SERRY, N.K.O. Torhout | €1.6m | €412,562 | 51.4% | - |
These companies have the same main activity as DR. KOEN SUY: human health activities (NACE 86109). They are comparable in size and age: total assets between €1.6m and €2.2m, founded between 2000 and 2009.
Official details
Source: KBO- Status
- Active since 18-12-2002Normal situation
- Activity
- Human health activitiesNACE 86109and 1 other
- Establishment unit
- 2.303.953.4032970 Schilde, since 16-12-2002
- Financial year end
- 31 December
- Peppol
- Reachable since 24-12-2025
Annual accounts 2025
- €2.3m▲ 2.0%
- Filing
- Filed on 24-07-2026, 7 days before the end of the filing period
Insights on DR. KOEN SUY
DR. KOEN SUY files the micro format. That format states no turnover. The gross margin rose from €296,879 in 2006 to €432,542 in 2025.
The balance sheet grew most from 2008 to 2010 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DR. KOEN SUY
- What is the company number of DR. KOEN SUY?
- The company number of DR. KOEN SUY is 0479.097.252. The VAT number is the same number with BE in front: BE 0479.097.252.
- Where is DR. KOEN SUY based?
- The registered office is at Boterlaarbaan 8, 2970 Schilde.Company details
- What does DR. KOEN SUY do?
- According to the KBO register, the main activity is human health activities (NACE 86109).
- What is the legal form of DR. KOEN SUY?
- DR. KOEN SUY is a private limited company (BV).
- When was DR. KOEN SUY founded?
- DR. KOEN SUY was founded on 18-12-2002.
- Is DR. KOEN SUY still active?
- Yes, DR. KOEN SUY is an active enterprise in the KBO register.
- What is the turnover of DR. KOEN SUY?
- The turnover in financial year 2025 is ≈ €640,000. This figure is estimated from the gross margin of €432,542 and 45 comparable companies (NACE 86). It probably lies between €540,000 and €820,000.Financials
- Is DR. KOEN SUY profitable?
- In financial year 2025, DR. KOEN SUY made a profit of €240,897.
- Where can I find the annual accounts of DR. KOEN SUY?
- DR. KOEN SUY filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DR. KOEN SUY due?
- DR. KOEN SUY must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.